WASSON GREGORY D 4

What Happened Gregory D. Wasson, a director of OptimizeRx Corp (OPRX), was granted 34,517 restricted stock units (RSUs) on June 9, 2026. The grant is reported as an award/acquisition (code A) at a reported price of $0.00 (no cash paid at grant). The RSUs represent a contingent right to receive shares of OptimizeRx common stock upon vesting.

Key Details

• Transaction date: 2026-06-09; Form 4 filed 2026-06-10 (appears timely).
• Transaction type/code: Award/Grant (A).
• Units granted: 34,517 RSUs; reported acquisition price: $0.00.
• Vesting: RSUs vest in full on the earlier of the first anniversary of the grant or the Company’s next annual meeting of shareholders (per footnote).
• Shares owned after transaction: not disclosed in this filing.
• Filing includes a standard legal remark clarifying the filing is not an admission of beneficial ownership.

Context RSUs are a form of equity compensation that convert to actual shares only upon vesting; no shares or cash changed hands at the time of grant. Such director awards are commonly part of routine compensation and do not, by themselves, indicate a buy/sell decision by the insider. If and when the RSUs vest, there may be tax withholding or sales to cover taxes depending on the company’s practices.